SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Clown-Free Zone... sorry, no clowns allowed

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (154891)3/7/2002 12:34:32 PM
From: reaper  Read Replies (2) of 436258
 
So DAK, you're LONG Sepracor now? They've blown through a LOT of cash ($160mm-ish in the first nine months of '01) gearing up for Soltera as well as spending on their other drug programs. With Soltera delayed, instead of killed, it seems to me like they're in a weird sort of limbo-land where they have to keep that spending up. They have $1.3 billion of way out of the money converts out there and cash, while still very high at about $900mm, will be dwindling in the next couple of years and its much less than their debt. It seems to me that they have had a LOT of regulatory setbacks in the last couple of years; is there anything else in the pipeline that looks big to you that is near-term (i.e. next two years). I'm not saying that I dis-agree, more that I don't know.

On Shire (SHPGY), what are the SI gurus saying? I personally think that Shire at $3 billion (net of cash) is a much better deal than Sepracor at $2 billion (market cap plus net debt). But then again I'm the same moron who liked CA @ $15.

While all this goes on ImClone quietly hit $30 today <g>

Cheers

EDIT -- you're long Cubist, yes? Nice move today.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext